NIH-funded research NIH-funded research

Understanding how PKC tweaks Kv7.2 to control neuron signals

Official title: Structural consequences of PKC-dependent phosphorylation of Kv7.2

Funded at University of Arkansas at Fayetteville · NIH-11394489 · Data updated 2026-11-12

A researcher is studying how a specific chemical modification (phosphorylation) changes a neuron potassium channel (Kv7.2) to affect brain excitability and epilepsy risk.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Arkansas at Fayetteville
NIH-funded
Lab location1 site (Fayetteville, United States)
Project startAugust 12, 2024
Project endJuly 31, 2027
Funding year2026
Award (this year)$249,000
NIH project number5R00GM146028-05
Project IDNIH-11394489 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with or at risk for epilepsy linked to Kv7.2 channel dysfunction, or those who could contribute samples for related molecular studies.

Less likely to help

People without Kv7.2-related epilepsy or related channel disorders may not directly benefit from this basic research.

What this research studies

This project looks at how Kv7.2 channel activity is controlled by multiple signaling partners, including PIP2 and calmodulin, and how PKC-related phosphorylation alters these interactions. Using advanced 3D structural methods and NMR, the team will test how phosphorylation at S520 and S527 changes binding and channel function. The goal is to reveal the molecular rules that tune M-channel activity and neuronal excitability, which could inform epilepsy therapies. The work is grounded in human biology and may identify targets relevant to neonatal epilepsy and related brain conditions.

Why it matters

Potential benefit: Insights could lead to new approaches for preventing or treating epilepsy linked to Kv7.2 channel dysfunction.

How similar studies have gone: Preliminary data and prior work on Kv7.2, PIP2, and CaM interactions suggest that these mechanisms influence channel activity; the proposed phosphorylation angle is a novel extension.

Where this research is happening

  • University of Arkansas at Fayetteville
    Fayetteville, United States
    Active

Researchers

  • Principal investigator: Archer, Crystal Rae — University of Arkansas at Fayetteville
  • Study coordinator: Archer, Crystal Rae

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.